Literature DB >> 21517920

Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease.

M-H Jen1, S Saxena, A Bottle, P Aylin, R C G Pollok.   

Abstract

BACKGROUND: Clostridium difficile (C. difficile) infection in hospitals in developed countries continues to be a major public health hazard despite increased control measures including review of antibiotic policies and hygiene measures. Patients with colitis are thought to be particularly vulnerable to C. difficile associated diarrhoea (CDAD). Identifying the clinical burden among hospitalised patients admitted with inflammatory bowel disease is an essential first step towards identifying and treating severe C. difficile infection in such individuals. AIM: To determine excess morbidity and in-hospital mortality associated with hospital acquired CDAD in patients with inflammatory bowel disease (IBD-CDAD-HAI) admitted to NHS hospitals in England compared with those admitted for inflammatory bowel disease alone.
METHODS: Time trends study of all admissions to NHS hospitals between 2002/03 and 2007/08. We developed case definitions for IBD-CDAD-HAI patients. The primary outcomes were in-hospital mortality and length of stay. The secondary outcome was gastrointestinal surgery.
RESULTS: Patients in the IBD-CDAD-HAI group were more likely to die in hospital (adjusted OR 6.32), had 27.9 days longer in-patient stays and higher gastrointestinal surgery rates (adjusted OR 1.87) than patients admitted for inflammatory bowel disease alone.
CONCLUSION: Patients with inflammatory bowel disease admitted to NHS hospitals in England with co-existent C. difficile infection are at risk of greater in-hospital mortality and morbidity than patients admitted for inflammatory bowel disease alone.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517920     DOI: 10.1111/j.1365-2036.2011.04661.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  33 in total

Review 1.  Quality of care delivered to hospitalized inflammatory bowel disease patients.

Authors:  Adam V Weizman; Geoffrey C Nguyen
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 2.  The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Curr Treat Options Gastroenterol       Date:  2017-09

3.  Clostridium difficile infection: risk factors, diagnosis and management.

Authors:  Christina M Surawicz
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

4.  Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  A N Ananthakrishnan; R Guzman-Perez; V Gainer; T Cai; S Churchill; I Kohane; R M Plenge; S Murphy
Journal:  Aliment Pharmacol Ther       Date:  2012-02-23       Impact factor: 8.171

Review 5.  Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.

Authors:  Geoffrey C Nguyen; Shane M Devlin; Waqqas Afif; Brian Bressler; Steven E Gruchy; Gilaad G Kaplan; Liliana Oliveira; Sophie Plamondon; Cynthia H Seow; Chadwick Williams; Karen Wong; Brian M Yan; Jennifer Jones
Journal:  Can J Gastroenterol Hepatol       Date:  2014-05

Review 6.  Fecal Microbiota Transplantation: Redefining Surgical Management of Refractory Clostridium difficile Infection.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

Review 7.  Management of acute severe ulcerative colitis.

Authors:  Saurabh Kedia; Vineet Ahuja; Rakesh Tandon
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

8.  Ulcerative colitis worsened after Clostridium difficile infection: efficacy of infliximab.

Authors:  Andrada Seicean; Anca Moldovan-Pop; Radu Seicean
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

9.  Faecal microbiota transplantation for recurring Clostridium difficile infection in a patient with Crohn's disease and ileorectal anastomosis.

Authors:  Asser Mathiassen Oppfeldt; Jens F Dahlerup; Lisbet A Christensen; Christian L Hvas
Journal:  BMJ Case Rep       Date:  2016-09-23

Review 10.  Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Nancy Fu; Titus Wong
Journal:  Curr Infect Dis Rep       Date:  2016-06       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.